FDA Import Refusal AEK-2877444-4/11/1 — Merck Sharp & Dohme BV
The FDA refused shipment AEK-2877444-4/11/1 from Merck Sharp & Dohme BV (Netherlands) on March 1, 2023. The refused product falls under Drugs and Biologics — LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 1, 2023
- Country
- Netherlands
- Product Category
- Drugs and Biologics
- Product Code
- 62OCE41 LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75